Cellectis S A Asset Turnover Ratio (CLLS), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cellectis S a   (NASDAQ: CLLS)
 

Cellectis S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cellectis S A asset turnover ratio, the ability of Cellectis S A 's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.36 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as CLLS's position remain challenging.

Within sector 59 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3670.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLLS Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change 54.58 % -21.32 % 59.6 % -21.32 % 9.05 %
Y / Y Revenue Change 75.76 % - 107.48 % - 23217.42 %
Asset Turnover Ratio (TTM) 0.36 - 0.25 - 0.23
CLLS's Total Ranking # 3670 # 0 # # #
Seq. Asset Change 97.51 % -53.55 % 115.3 % -21.74 % 0.53 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 60
Healthcare Sector # 542
Overall Market # 3670

Asset Turnover Ratio Statistics
High Average Low
24.83 6.29 0.7
(Dec 31 2022)   0




CLLS Company Profile • Back to CLLS Efficiency Comparisons • Compare CLLS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Msa Safety Inc  0.76 $ 1,874.113  Millions$ 2,473.512  Millions
Bioaffinity Technologies Inc   0.75 $ 6.162  Millions$ 8.201  Millions
Pharming Group N v   0.75 $ 375.634  Millions$ 499.963  Millions
Vivos Therapeutics Inc   0.75 $ 16.542  Millions$ 22.028  Millions
Harmony Biosciences Holdings inc   0.75 $ 868.111  Millions$ 1,160.848  Millions
Masimo Corp  0.74 $ 1,526.200  Millions$ 2,053.025  Millions
Adapthealth Corp   0.74 $ 3,244.857  Millions$ 4,372.069  Millions
Delcath Systems Inc   0.74 $ 83.762  Millions$ 113.031  Millions
Cytosorbents Corporation  0.74 $ 34.921  Millions$ 47.176  Millions
Amicus Therapeutics inc   0.74 $ 632.828  Millions$ 855.956  Millions
Harrow Inc   0.74 $ 270.837  Millions$ 367.938  Millions
Mdxhealth Sa  0.73 $ 107.875  Millions$ 147.953  Millions
Tenet Healthcare Corp  0.73 $ 21,310.000  Millions$ 29,257.750  Millions
Novo Nordisk A  0.72 $ 309,064.000  Millions$ 428,503.574  Millions
Journey Medical Corp  0.72 $ 61.858  Millions$ 86.475  Millions
Tg Therapeutics Inc   0.72 $ 616.287  Millions$ 861.895  Millions
Lantheus Holdings Inc   0.71 $ 1,540.952  Millions$ 2,168.775  Millions
Capsovision Inc   0.71 $ 12.426  Millions$ 17.544  Millions
Heartflow Inc   0.70 $ 174.528  Millions$ 250.479  Millions
Neurocrine Biosciences Inc   0.69 $ 2,860.500  Millions$ 4,118.675  Millions
Stereotaxis Inc   0.69 $ 32.071  Millions$ 46.179  Millions
Illumina Inc   0.69 $ 4,343.000  Millions$ 6,272.500  Millions
Telix Pharmaceuticals Ltd  0.69 $ 803.438  Millions$ 1,163.986  Millions
Quest Diagnostics Inc  0.69 $ 11,035.000  Millions$ 16,047.000  Millions
Mirum Pharmaceuticals Inc   0.69 $ 521.312  Millions$ 760.999  Millions
Biomerica Inc   0.68 $ 4.458  Millions$ 6.530  Millions
Inotiv Inc   0.68 $ 514.027  Millions$ 757.788  Millions
Akebia Therapeutics Inc   0.68 $ 236.196  Millions$ 349.124  Millions
Strata Critical Medical Inc   0.67 $ 197.126  Millions$ 292.255  Millions
Phathom Pharmaceuticals Inc   0.67 $ 175.110  Millions$ 260.967  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.